期刊
CHEMICAL SOCIETY REVIEWS
卷 42, 期 14, 页码 6186-6199出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c3cs35532b
关键词
-
资金
- Johanna Mahlke geb. Obermann Foundation
- DACH program of the Austrian Science Fund (FWF) [I496-B11]
- Swiss National Science Foundation
- University of Groningen
Mass spectrometry (MS) has emerged as an important tool for studying anticancer metallodrugs in complex biological samples and for characterising their interactions with biomolecules and potential targets on a molecular level. The exact modes-of-action of these coordination compounds and especially of next generation drug candidates have not been fully elucidated. Due to the fact that DNA is considered a crucial target for platinum chemotherapeutics, metallodrug-DNA binding studies dominated the field for a long time. However, more recently, alternative targets were considered, including enzymes and proteins that may play a role in the overall pharmacological and toxicological profile of metallodrugs. This review focuses on MS-based techniques for studying anticancer metallodrugs in vivo, in vitro and in situ to delineate their modes-of-action.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据